tiprankstipranks

STEWART ABBOT Insider Profile

4 Followers
STEWART ABBOT, CDO at Fate Therapeutics, holds 64.92K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in Adicet Bio (Ticker: ACET), holds ― shares in Turnstone Biologics Corp. (Ticker: TSBX). Most recently, STEWART ABBOT Bought ― shares of Fate Therapeutics on May 16, 2018 for an estimated value of 139.41K.
tipranks
STEWART ABBOT

STEWART ABBOT
Fate Therapeutics (FATE)
CDO

Not Ranked
STEWART ABBOT has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$265K
100.00%
0.00%
0.00%
A breakdown of STEWART ABBOT's holdings

Insider Roles

Fate Therapeutics
(FATE)
CDO
Adicet Bio
(ACET)
Former Chief Scientific and Operating Officer
Turnstone Biologics Corp.
(TSBX)
Chief Scientific Officer
Roles that STEWART ABBOT holds in companies

Most Profitable Insider Trade

Stock:
Fate Therapeutics
(FATE)
Rating:Informative Buy
Date:May 16, 2018 - May 16, 2019
Return:+92.00%
The most profitable trade made by STEWART ABBOT

STEWART ABBOT's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fate Therapeutics
May 16, 2018
CDO
Informative Buy
139.41K
$264.86K
Adicet Bio
Former Chief Scientific and Operating Officer
Turnstone Biologics Corp.
Chief Scientific Officer
List of latest transactions for each holding click on a transaction to see STEWART ABBOT's performance on stock

STEWART ABBOT insider profile FAQ

What is the percentage of profitable transactions made by STEWART ABBOT?
The percentage of profitable transactions made by STEWART ABBOT is ―.
    What is the average return per transaction made by STEWART ABBOT?
    The average return per transaction made by STEWART ABBOT is ―.
      What stocks does STEWART ABBOT hold?
      STEWART ABBOT holds: FATE, ACET, TSBX stocks.
        What was STEWART ABBOT’s latest transaction?
        STEWART ABBOT latest transaction was an Informative Buy of $139.41K.
          What was STEWART ABBOT's most profitable transaction?
          STEWART ABBOT’s most profitable transaction was an Informative Buy of FATE stock on May 16, 2018. The return on the trade was 92.00%.
            What is STEWART ABBOT's role in Fate Therapeutics?
            STEWART ABBOT's role in Fate Therapeutics is CDO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.